Target Details
| UniProt AC | P42338 |
|---|---|
| Gene Symbol | PIK3CB |
| Protein Name | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00454 (PI3_PI4_kinase) PF00792 (PI3K_C2) PF02192 (PI3K_p85B) PF00794 (PI3K_rbd) PF00613 (PI3Ka) |
Summary
- Multi-target molecules 1,951
- Clinical molecules 55
- Avg pChEMBL 7.07
KEGG Pathways (109)
- AGE-RAGE signaling pathway in diabetic complications
- AMPK signaling pathway
- Acute myeloid leukemia
- Aldosterone-regulated sodium reabsorption
- Alzheimer disease
- Amoebiasis
- Apoptosis
- Autophagy - animal
- Axon guidance
- B cell receptor signaling pathway
- Bacterial invasion of epithelial cells
- Breast cancer
- C-type lectin receptor signaling pathway
- Carbohydrate digestion and absorption
- Cellular senescence
- Central carbon metabolism in cancer
- Chagas disease
- Chemical carcinogenesis - reactive oxygen species
- Chemical carcinogenesis - receptor activation
- Chemokine signaling pathway
- Choline metabolism in cancer
- Cholinergic synapse
- Chronic myeloid leukemia
- Colorectal cancer
- Coronavirus disease - COVID-19
- Diabetic cardiomyopathy
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- Epstein-Barr virus infection
- ErbB signaling pathway
- Estrogen signaling pathway
- Fc epsilon RI signaling pathway
- Fc gamma R-mediated phagocytosis
- Fluid shear stress and atherosclerosis
- Focal adhesion
- FoxO signaling pathway
- Gastric cancer
- Glioma
- GnRH secretion
- Growth hormone synthesis, secretion and action
- HIF-1 signaling pathway
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Herpes simplex virus 1 infection
- Hormone signaling
- Human T-cell leukemia virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- IgSF CAM signaling
- Inflammatory mediator regulation of TRP channels
- Influenza A
- Inositol phosphate metabolism
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Leukocyte transendothelial migration
- Lipid and atherosclerosis
- Longevity regulating pathway
- Longevity regulating pathway - multiple species
- Measles
- Melanoma
- Metabolic pathways
- MicroRNAs in cancer
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Neutrophil extracellular trap formation
- Non-alcoholic fatty liver disease
- Non-small cell lung cancer
- Osteoclast differentiation
- PD-L1 expression and PD-1 checkpoint pathway in cancer
- PI3K-Akt signaling pathway
- Pancreatic cancer
- Pathways in cancer
- Phosphatidylinositol signaling system
- Phospholipase D signaling pathway
- Platelet activation
- Platinum drug resistance
- Prion disease
- Progesterone-mediated oocyte maturation
- Prolactin signaling pathway
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Ras signaling pathway
- Regulation of actin cytoskeleton
- Regulation of lipolysis in adipocytes
- Relaxin signaling pathway
- Renal cell carcinoma
- Salmonella infection
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- Small cell lung cancer
- Sphingolipid signaling pathway
- Spinocerebellar ataxia
- T cell receptor signaling pathway
- TNF signaling pathway
- Thyroid hormone signaling pathway
- Toll-like receptor signaling pathway
- Type II diabetes mellitus
- VEGF signaling pathway
- Viral carcinogenesis
- Yersinia infection
- cAMP signaling pathway
- mTOR signaling pathway
Active Molecules (1,951)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
BBRINJUWZRLWKK
|
8.0 | IC50 | 5 | — | |
QQBVZBSMGUVONA
|
8.0 | IC50 | 5 | — | |
QXEBUDGMCKMQGM
|
8.0 | IC50 | 4 | — | |
SVADRSXTQMXCKW
|
8.0 | IC50 | 4 | — | |
JVFSDXQBBQIWBM
|
8.0 | IC50 | 4 | — | |
MVPHPMFJESRQLE
|
8.0 | IC50 | 5 | — | |
DDYGLALBILACTA
|
8.0 | IC50 | 5 | — | |
GFFQKKWMLSGONS
|
8.0 | IC50 | 2 | — | |
CPRAGQJXBLMUEL
|
8.0 | IC50 | 2 | — | |
GPBJZHQBTXHZRQ
|
8.0 | IC50 | 5 | — | |
IRTDIKMSKMREGO
|
8.0 | IC50 | 3 | — | |
KHJNCYCXAKBENU
|
8.0 | IC50 | 4 | — | |
NWMAIWLSPZJKEN
|
8.0 | IC50 | 3 | — | |
ONCWHTARVIIEDJ
|
8.0 | IC50 | 5 | — | |
QUDFJWGWCAJQGK
|
8.0 | IC50 | 5 | — | |
RTIHEFJLMDWVJV
|
8.0 | IC50 | 4 | — | |
RTXWPOABAGXULX
|
8.0 | IC50 | 6 | — | |
UOYCMRSNQQOELB
|
8.0 | IC50 | 3 | — | |
VENFEBYOSUGVRR
|
8.0 | IC50 | 3 | — | |
XXVQUOSJLYEXMX
|
8.0 | Ki | 5 | — | |
YCXOFUQHGUQXFZ
|
8.0 | IC50 | 3 | — | |
YOURQHZNTIANMX
|
8.0 | IC50 | 5 | — | |
YQIZUUKETJHIOY
|
8.0 | IC50 | 2 | — | |
ZCBWPTBPKMKOLE
|
8.0 | IC50 | 5 | — | |
LXCSAPOGAXFOIJ
|
8.0 | IC50 | 3 | — | |
YZPXOELSBMGYGO
|
8.0 | IC50 | 3 | — | |
AFXCIEBLRXCDNI
|
8.0 | IC50 | 2 | — | |
GLORCTPRDHXJPK
|
8.0 | IC50 | 2 | — | |
MFZIKQUQYUQHHO
|
8.0 | IC50 | 5 | — | |
MJORCRPQWCUGJG
|
8.0 | IC50 | 3 | — | |
NFMJPNIMDSAFQE
|
8.0 | IC50 | 6 | — | |
NLZNQTSAEGRBEQ
|
8.0 | IC50 | 8 | — | |
PQDLHRVPXZBOAV
|
8.0 | IC50 | 2 | — | |
QBDMEXDBIHVBTA
|
8.0 | Ki | 3 | — | |
ULKIEJUPHQMXQN
|
8.0 | IC50 | 5 | — | |
UNRKTJKQLXZCJK
|
8.0 | IC50 | 2 | — | |
UVJBPMCZKOGSIP
|
8.0 | IC50 | 4 | — | |
WARUZPFHLRLCHE
|
8.0 | IC50 | 7 | — | |
XDLCZYNDGPSHBI
|
8.0 | Ki | 4 | — | |
DSJLYDGCBXUTCD
|
8.0 | IC50 | 3 | — | |
TVZPBIBWLNLUKK
|
7.9 | IC50 | 2 | — | |
YZIQNVDBRMRXLM
|
7.9 | IC50 | 4 | — | |
BTHPXDNRFHNRDI
|
7.9 | Ki | 5 | — | |
DQFBCPJYUUEXAD
|
7.9 | IC50 | 5 | — | |
HXIMOOZRCPTJDQ
|
7.9 | IC50 | 5 | — | |
ISIOGRVXKGDUFP
|
7.9 | IC50 | 5 | — | |
KKDXZRIKKMODBM
|
7.9 | IC50 | 2 | — | |
LEXMMFPAPDGYGZ
|
7.9 | IC50 | 7 | — | |
LILBAKYEAUUWIF
|
7.9 | IC50 | 5 | — | |
OYJBSHKZMWMHDE
|
7.9 | IC50 | 3 | — |